证券日报网讯12月23日，三星医疗（601567）在互动平台回答投资者提问时表示，公司主营业务为智能 配用电及医疗服务两大板块，未涉及可控核聚变领域。 ...

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：贵司是否涉及可控核聚变领域？ 三星医疗（601567.SH）12月23日在投资者互动平台表示，公司主营业务为智能配用电及医疗服务两大 板块，未涉及可控核聚变领域。 ...

针对上述提问，三星医疗回应称："尊敬的投资者，您好！公司主营业务为智能配用电及医疗服务两大 板块，未涉及可控核聚变领域。感谢您的关注！" 有投资者在互动平台向三星医疗提问："贵司是否涉及可控核聚变领域？" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 ...

格隆汇12月23日丨三星医疗(601567.SH)在投资者互动平台表示，公司主营业务为智能配用电及医疗服 务两大板块，未涉及可控核聚变领域。 ...

Core Viewpoint - Samsung Medical reported a decline in Q3 revenue and net profit, primarily due to slow domestic order deliveries and low-margin overseas orders, but expects recovery in gross margins and prices with upcoming tenders [1][2]. Financial Performance - Q3 revenue reached 3.108 billion yuan, down 9.56% year-on-year and 28.42% quarter-on-quarter; net profit attributable to shareholders was 298 million yuan, up 55.22% year-on-year and down 59.74% quarter-on-quarter [1]. - For the first three quarters of 2025, revenue was 11.08 billion yuan, up 6.19% year-on-year; net profit was 1.528 billion yuan, down 15.85% year-on-year, with a gross margin of 28.46%, down 7.74 percentage points [2]. Order Backlog and Market Expansion - As of Q3 2025, the total order backlog reached 17.914 billion yuan, up 14.69% year-on-year, with overseas distribution orders at 2.169 billion yuan, up 125.45% [2]. - The company is focusing on expanding its presence in Europe, the Middle East, and Latin America, achieving initial orders in several countries, including Hungary and Romania [2]. Business Development - The company maintains a leading position in domestic network business and is actively expanding its customer base outside the network, targeting large clients in the renewable energy sector and new market segments [3]. Profit Forecast and Valuation - The company has adjusted its net profit forecasts for 2025-2027 downwards by 16.23%, 15.21%, and 10.60% respectively, with expected net profits of 2.261 billion, 2.765 billion, and 3.491 billion yuan [4]. - The target price is set at 28.32 yuan, maintaining a "buy" rating based on adjusted earnings multiples [4].

Core Viewpoint - Samsung Medical (601567.SH) has developed an integrated solution in the field of smart energy management to meet the needs of domestic and international customers [1] Group 1 - The company has formed a comprehensive solution in smart power distribution, which includes smart meters, smart terminals, communication modules, system software, transformers, box-type substations, switch cabinets, power boxes, photovoltaic/wind power box transformers, charging piles, inverters, and energy storage-related products [1] - Currently, the company does not have any military-related business [1]

Core Viewpoint - Samsung Medical (601567.SH) has developed an integrated solution in the field of smart energy management to meet the needs of domestic and international customers, which includes various products and systems [1] Group 1 - The company has formed a comprehensive solution in smart power distribution, which encompasses smart meters, smart terminals, communication modules, system software, transformers, box-type substations, switch cabinets, power boxes, photovoltaic/wind power box transformers, charging piles, inverters, and energy storage-related products [1] - Currently, the company does not have any military-related business [1]

Core Viewpoint - Weisheng Holdings (03393) has seen a significant stock price increase of over 25% following the release of its interim results, with a current trading price of 11.19 HKD and a trading volume of 47.63 million HKD [1] Financial Performance - The company reported a revenue of 4.39 billion RMB, representing a year-on-year increase of 17.34% [1] - Net profit attributable to shareholders reached 440 million RMB, marking a year-on-year increase of 32.81% [1] Market Analysis - CICC's report indicates that Weisheng Holdings' performance exceeded expectations, driven by expansion in external markets such as communications, and better-than-industry performance in domestic meter deliveries and collections [1] - Citigroup's report highlights that the net profit for the first half of the year rose by 32.8% to 440 million RMB, surpassing the market's expectation of a full-year profit increase of 28.3% to 906 million RMB [1] Business Segments - The revenue from the smart distribution and utilization system and solutions (ADO) segment grew by 9.2% year-on-year, primarily due to strong product demand from overseas data centers [1] - Management maintains a dividend payout ratio of 50% for 2025 and capital expenditure guidance, anticipating strong performance in new orders from overseas data centers, which is expected to support a 21% growth in ADO business revenue for the year [1]

Core Viewpoint - The report highlights that Haixing Electric's performance in the first half of 2025 fell short of expectations due to increased counter-cyclical investments and industry cycle impacts, leading to a decline in both revenue and net profit [2][4]. Financial Summary - Haixing Electric reported a total revenue of 1.92 billion yuan for the first half of 2025, representing a year-on-year decrease of 14.7% [2]. - The net profit attributable to shareholders was 400 million yuan, down 25.7% year-on-year [2]. - The comprehensive gross margin for the first half of 2025 was 41.56%, a decrease of 2.64% compared to the same period last year [2]. - The period expense ratio increased to 17.58%, up 0.57% from the previous year [2]. Business Development - The company is actively participating in domestic and overseas markets, securing significant contracts such as 140 million yuan from the State Grid and 49.9 million yuan from Southern Power Grid [3]. - Haixing Electric is expanding its marketing channels in key countries and new markets, with the launch of the "Orca" platform and the commencement of operations at a smart ultrasonic water meter factory in South Africa [3]. - The company aims for multi-market and multi-category collaborative development while consolidating its domestic base and expanding overseas [3]. Competitive Advantage - Haixing Electric focuses on providing comprehensive solutions and localized strategies, enhancing its brand competitiveness [4]. - The company has achieved a revenue share of approximately 60% from system software and solutions in its overseas smart electricity business in 2024 [4]. - By leveraging product and service capabilities, Haixing Electric has established deep customer relationships and built a competitive brand advantage [4]. Profit Forecast and Investment Rating - The projected net profits for Haixing Electric from 2025 to 2027 are 1.023 billion yuan, 1.188 billion yuan, and 1.387 billion yuan, respectively, with corresponding EPS of 2.10, 2.44, and 2.85 yuan [4]. - The current stock price corresponds to PE ratios of 13, 11, and 10 times for 2025 to 2027 [4]. - The report maintains a "strong buy" rating for the company [4].

Core Viewpoint - Samsung Medical Electric Co., Ltd. reported a strong performance in the first half of 2025, with significant growth in both revenue and net profit, driven by overseas expansion and strategic focus on high-end markets [1][2]. Group 1: Financial Performance - The company achieved operating revenue of 7.972 billion yuan, representing a year-on-year increase of 13.93% [1]. - Net profit attributable to shareholders reached 1.23 billion yuan, up 6.93% year-on-year [1]. Group 2: Overseas Strategy - Overseas revenue in the smart distribution sector reached 1.495 billion yuan, marking a substantial growth of 50.89% [1]. - The company made significant inroads into European, Middle Eastern, and Latin American markets, with successful first orders in Hungary, Romania, and Kyrgyzstan [1]. - Samsung Medical is enhancing its local operations by establishing a sales company in Hungary to support overseas distribution business [1]. Group 3: Domestic Market Development - In the domestic market, Samsung Medical continues to lead in the power grid sector, actively targeting major clients in the new energy sector and achieving rapid breakthroughs [1]. - The company is also focusing on new market opportunities in the petrochemical and data center sectors, securing multi-million yuan orders [1]. Group 4: Order Backlog - As of June 30, 2025, the total order backlog stood at 17.632 billion yuan, reflecting an 18.39% year-on-year increase [2]. - The overseas distribution order backlog reached 2.182 billion yuan, showing a remarkable growth of 123.96% [2]. Group 5: Medical Services Sector - In the medical services sector, Samsung Medical is concentrating on chain operations, discipline construction, and quality management, particularly in the rehabilitation field [2].